Köpenysejtes limfóma: vizsgálatok itt: Olaszország
18 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 12.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleAn early study to investigate a new medicine for Subjects with Relapsed or Refractory Non-Hodgkin Lymphomas (R/R NHL)
- Where
- Bergamo, Bologna, Naples
- Életkor
- 18 év and over
- People
- 204 worldwide
- Run by
- Celgene Corp.
See details and how to joinNCT03930953 · EU 2024-515690-10-00 - 3. fázisTaking peopleA Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
- Where
- Alessandria, Bergamo, Bologna, Milan, Turin
- Életkor
- 18 év and over
- People
- 182 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT06084936 - 1. fázisTaking peopleA Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
- Where
- Bologna, Naples, Rozzano
- Életkor
- 18 év and over
- People
- 215 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07101328 · EU 2025-524180-20-00 - 2. fázisTaking peopleVenetoclax in combination with Ibrutinib and Rituximab or conventional chemotherapy (Bendamustine) and Ibrutinib and Rituximab in patients with Mantle Cell Lymphoma.
- Where
- Alexandria, Bologna, Brescia, Catania, Cuneo, Florence, Genoa, Milan, Novara, Pavia, Piacenza, Rimini, Rome, Trieste, Turin, Verona
- Életkor
- 18 év and over
- People
- 235 worldwide
- Run by
- Universitatsmedizin der Johannes Gutenberg-Universitat Mainz KöR
See details and how to join2022-501808-96-00 · EU 2022-501808-96-00 - 1. fázisTaking peopleIKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas
- Where
- Candiolo, Milan
- Életkor
- 18 év and over
- People
- 140 worldwide
- Run by
- Iksuda Therapeutics Ltd.
See details and how to joinNCT05365659 - 1. fázisTaking peopleA Study of ARC-02 in B-cell NHL
- Where
- Aviano, Bergamo, Bologna, Rozzano
- Életkor
- 18 év and over
- People
- 140 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT07691606 · EU 2026-525606-35-00 - 3. fázisTaking peopleA Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
- Where
- Bologna, Lecce, Meldola, Trieste, Verona
- Életkor
- 18 év and over
- People
- 300 worldwide
- Run by
- BeOne Medicines
See details and how to joinNCT06742996 · EU 2024-515593-27-00 - 1/2. fázisTaking peopleA Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
- Where
- Bologna, Milan
- Életkor
- 18 év and over
- People
- 408 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06564038 · EU 2024-515034-33-00 - 2. fázisTaking peopleStudy carried out at multiple centers to test Glofitamab in patients with mantle cell lymphoma who did not respond well to, or relapsed after, CAR T-cell therapy.
- Where
- Alexandria, Bologna, Brescia, Florence, Genoa, Milan, Palermo, Pescara, Pisa, Reggio Calabria, Rome, Turin, Verona, Vicenza
- Életkor
- 18 év and over
- People
- 41
- Run by
- Fondazione Italiana Linfomi Ets
See details and how to join2025-523428-39-00 · EU 2025-523428-39-00 - 1/2. fázisTaking peopleA Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
- Where
- Bologna, Milan, Roma, Verona
- Életkor
- 18 év and over
- People
- 689 worldwide
- Run by
- BeOne Medicines
See details and how to joinNCT05006716 · EU 2022-502157-33-00 - 1/2. fázisTaking peopleA Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
- Where
- Bologna, Milan
- Életkor
- 18 év and over
- People
- 174 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06542250 - 3. fázisTaking peopleA Study to Compare the Efficacy and Safety of Glofitamab as a Single Agent Versus Investigator’s Choice in Patients with Relapsed/Refractory Mantle Cell Lymphoma
- Where
- Alexandria, Bergamo, Bologna, Milan, Turin
- Életkor
- 18 év and over
- People
- 39 worldwide
- Run by
- F. Hoffmann-La Roche AG
See details and how to join2023-503206-37-00 · EU 2023-503206-37-00 - 1. fázisTaking peopleA Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
- Where
- Bologna, Brescia, Milan, Rome
- Életkor
- 18 év and over
- People
- 572 worldwide
- Run by
- Nurix Therapeutics, Inc.
See details and how to joinNCT05131022 · EU 2023-510541-25-00 - 2. fázisTaking peopleStudy With Glofitamab in Patients With MCL and Inadequate Response or Relapse Following CAR T-cell Therapy
- Where
- Alessandria, Bologna, Brescia, Florence, Genova, Milan, Palermo, Pescara, Pisa, Reggio Calabria, Roma, Torino, Verona, Vicenza
- Életkor
- 18 év and over
- People
- 41
- Run by
- Fondazione Italiana Linfomi - ETS
See details and how to joinNCT07453095 - 2. fázisTaking peoplePirtobrUtinib as frontline Therapy for elderly unfit/frail patient with MAntle cell lymphoma: a phase II study of the Fondazione Italiana Linfomi (FIL)
- Where
- Ancona, Avellino, Bologna, Brescia, Catania, Meldola, Milan, Palermo, Parma, Pescara, Piacenza, Ponderano, Reggio Emilia, Rozzano, Siena, Terni, Treviso, Varese, Verona, Vicenza
- Életkor
- 65 év and over
- People
- 56
- Run by
- Fondazione Italiana Linfomi Ets
See details and how to join2025-521666-10-01 · EU 2025-521666-10-01 - 1. fázisTaking peopleStudy of SGR-1505 in Mature B-Cell Neoplasms
- Where
- Alexandria, Milan, Turin, Verona
- Életkor
- 18 év and over
- People
- 98 worldwide
- Run by
- Schrödinger, Inc.
See details and how to joinNCT05544019 · EU 2023-505204-34-00 - 2. fázisNot yet taking people in OlaszországPirtobrUtinib as Frontline Therapy for Elderly Unfit/Frail Patient With MAntle Cell Lymphoma
- Where
- Ancona, Avellino, Biella, Bologna, Brescia, Catania, Meldola, Milan, Palermo, Parma, Pescara, Piacenza, Reggio Emilia, Rozzano, Siena, Terni, Treviso, Varese, Verona, Vicenza
- Életkor
- 70 év and over
- People
- 56
- Run by
- Fondazione Italiana Linfomi - ETS
See details and how to joinNCT07207785 - No phaseTaking peopleItalian Observational Study on CAR-T Therapy for Lymphoma
- Where
- Milan
- Életkor
- 18 év and over
- People
- 5300
- Run by
- Paolo Corradini
See details and how to joinNCT06339255